The prestigious PharmaTimes Marketer of the Year competition closes for entries on 1 September. It only takes a few seconds to fill out the online entry form and then you don’t need to do anything else until the day of
read moreNovo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out based at Unit DX science incubator in Bristol, UK. More: Novo buys UK group Ziylo Source: News
read moreChina’s former FDA chief resigns from his leadership role at the new market regulatory agency over the latest vaccine scandal; Astellas buys U.K. gene therapy developer Quethera for $109 million; and the FDA found quality-control problems at Zhejiang Huahai Pharmaceutical
read moreEisai and Merck’s fast-growing Lenvima’s got a brand-new market—and Bayer’s Nexavar has some company in the previously untreated liver cancer arena. More: Eisai, Merck take on Bayer's Nexavar with new liver cancer nod for Lenvima Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals